Government · 1 deal
United States government agency funding health research and innovation.
Every published round U.S. Advanced Research Projects Agency for Health (ARPA-H) took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Micro-X Ltd | Grant | 26 Feb 2025 | US$16m+ (A$25.3m+) | Lead | Dealroom, @AuManufacturing (7 Jul 2025), @AuManufacturing (22 Jun 2025), Medianet, @AuManufacturing (8 Dec 2024) |
Companies U.S. Advanced Research Projects Agency for Health (ARPA-H) has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Micro-X Ltd | 26 Feb 2025, Grant | 1 | 1 |
Fund closes reported for U.S. Advanced Research Projects Agency for Health (ARPA-H), as distinct from the investments it has made.
Companies U.S. Advanced Research Projects Agency for Health (ARPA-H) has backed that another company then bought. An exit for the holding, not a deal U.S. Advanced Research Projects Agency for Health (ARPA-H) did.
Stories naming U.S. Advanced Research Projects Agency for Health (ARPA-H). Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Micro-X's Head CT test bench produced its first 3D images, qualifying it for an MRFF progress payment, with US ARPA-H contracts worth $25 million announced this week supporting full-body CT development.